Holdings
Elmind Capital, LP
As of Jun 30, 2026, Elmind Capital, LP reported 29 positions worth US$355M. Largest: Cogent Biosciences, Inc., Syndax Pharmaceuticals, Inc. and Celldex Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Cogent Biosciences, Inc. | 1.17M | US$45.3M | no change | Jun 30, 2026 |
| Syndax Pharmaceuticals, Inc. | 1.85M | US$40.6M | no change | Jun 30, 2026 |
| Celldex Therapeutics, Inc. | 990K | US$36.8M | +125K | Jun 30, 2026 |
| Relay Therapeutics, Inc. | 1.47M | US$27.4M | +928K | Jun 30, 2026 |
| Vaxcyte, Inc. | 452K | US$26.3M | +136K | Jun 30, 2026 |
| Vera Therapeutics, Inc. | 437K | US$18.7M | −45,982 | Jun 30, 2026 |
| Viridian Therapeutics, Inc. | 985K | US$18.1M | +450K | Jun 30, 2026 |
| Cytomx Therapeutics, Inc. | 4.55M | US$17.1M | no change | Jun 30, 2026 |
| Travere Therapeutics, Inc. | 293K | US$16.6M | +115K | Jun 30, 2026 |
| Beam Therapeutics Inc. | 476K | US$16.3M | no change | Jun 30, 2026 |